Evaluation of microRNA expression profiles in triple-negative (ER, PR and Her2/neu) breast cancer patients with and without germ-line BRCA mutations

被引：0
|
作者：
Erturk, E. [1 ]
Cecener, G. [2 ]
Egeli, U. [2 ]
Tunca, B. [2 ]
Tezcan, G. [2 ]
Gokgoz, S. [3 ]
Tolunay, S. [4 ]
Tasdelen, I. [3 ]
机构：
[1] Uludag Univ, Vocat Sch Hlth Serv, Bursa, Turkey
[2] Uludag Univ, Fac Med, Dept Med Biol, Bursa, Turkey
[3] Uludag Univ, Fac Med, Dept Gen Surg, Bursa, Turkey
[4] Uludag Univ, Fac Med, Dept Pathol, Bursa, Turkey
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)50355-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
398
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [1] MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer
    Radojicic, Jelena
    Zaravinos, Apostolos
    Vrekoussis, Thomas
    Kafousi, Maria
    Spandidos, Demetrios A.
    Stathopoulos, Efstathios N.
    CELL CYCLE, 2011, 10 (03) : 507 - 517
  • [2] EVALUATION OF BRCA 1-2 GENE MUTATIONS IN PATIENTS WITH TRIPLE NEGATIVE AND ER(-), PR(-), HER-2(+) BREAST CANCER
    Uzal, M. C.
    Sener, S.
    Ozen, A.
    Cakina, S.
    Sipahi, T.
    Cosar, R.
    Gulyasar, T.
    Karagol, H.
    Yalcin, O.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S299 - S299
  • [3] Outcomes of ER, PR, HER2, and triple-negative mutated breast cancer with brain metastasis.
    O'Shea, Patrick Joseph
    Tatineni, Vineeth
    Rauf, Yasmeen
    Jia, Xuefei
    Murphy, Erin Sennett
    Chao, Samuel T.
    Suh, John H.
    Peereboom, David M.
    Ahluwalia, Manmeet Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations
    Soley Bayraktar
    Angelica M. Gutierrez-Barrera
    Diane Liu
    Tunc Tasbas
    Ugur Akar
    Jennifer K. Litton
    E. Lin
    Constance T. Albarracin
    Funda Meric-Bernstam
    Ana M. Gonzalez-Angulo
    Gabriel N. Hortobagyi
    Banu K. Arun
    Breast Cancer Research and Treatment, 2011, 130
  • [5] Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations
    Bayraktar, Soley
    Gutierrez-Barrera, Angelica M.
    Liu, Diane
    Tasbas, Tunc
    Akar, Ugur
    Litton, Jennifer K.
    Lin, E.
    Albarracin, Constance T.
    Meric-Bernstam, Funda
    Gonzalez-Angulo, Ana M.
    Hortobagyi, Gabriel N.
    Arun, Banu K.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (01) : 145 - 153
  • [6] Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer
    Perez, Edith A.
    Patel, Tejal
    Moreno-Aspitia, Alvaro
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 121 (02) : 261 - 271
  • [7] Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer
    Edith A. Perez
    Tejal Patel
    Alvaro Moreno-Aspitia
    Breast Cancer Research and Treatment, 2010, 121 : 261 - 271
  • [8] Triple-negative (ER, PgR, HER-2/neu) breast cancer in Indian women
    Patil, Vinayak W.
    Singhai, Rajeev
    Patil, Amit V.
    Gurav, Prakash D.
    BREAST CANCER-TARGETS AND THERAPY, 2011, 3 : 9 - 19
  • [9] BRCA2 germ-line mutations in Spanish male breast cancer patients
    Díez, O
    Cortés, J
    Domènech, M
    Pericay, C
    Brunet, J
    Alonso, C
    Baiget, M
    ANNALS OF ONCOLOGY, 2000, 11 (01) : 81 - 84
  • [10] BRCA2 Mutations and Triple-Negative Breast Cancer
    Meyer, Peter
    Landgraf, Katharina
    Hoegel, Bernhard
    Eiermann, Wolfgang
    Ataseven, Beyhan
    PLOS ONE, 2012, 7 (05):
12345